Regulus Therapeutics
RGLS
#8760
Rank
NZ$0.17 B
Marketcap
$2.63
Share price
10.64%
Change (1 day)
14.92%
Change (1 year)

Earnings for Regulus Therapeutics (RGLS)

Earnings in 2024 (TTM): -NZ$57.47 Million

According to Regulus Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -NZ$49.66 Million a decrease over its 2022 earnings that were of -NZ$46.63 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regulus Therapeutics from 2012 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$57.47 Million15.72%
2023 -NZ$49.66 Million6.51%
2022 -NZ$46.63 Million2.53%
2021 -NZ$45.48 Million93.59%
2020 -NZ$23.49 Million-15.41%
2019 -NZ$27.77 Million-64.46%
2018 -NZ$78.13 Million-33.26%
2017 -NZ$0.12 Billion-13.98%
2016 -NZ$0.14 Billion44.77%
2015 -NZ$94.01 Million-1.63%
2014 -NZ$95.57 Million203.6%
2013 -NZ$31.48 Million8.65%
2012 -NZ$28.97 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$7.03 B-12,017.11%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$12.49 B-21,265.86%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$2.21 B-3,854.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$15.86 B-26,963.62%๐Ÿ‡ฌ๐Ÿ‡ง UK
-NZ$0.32 Billion 433.96%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.35 Billion 489.91%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$11.61 Billion 19,557.70%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.2 Billion 236.16%๐Ÿ‡บ๐Ÿ‡ธ USA